|
| Issue Date | Title | Author(s) |
| 2024 | Design, synthesis and molecular modeling of Pyrazolo [1, 5-a] pyrimidine derivatives as dual inhibitors of CDK2 and TRKA kinases with Antiproliferative activity | Attia, Mohamed H; Taher, Azza T; Abdel-Aziz, Hatem A; Abou El Ella, Dalal A; Nermin Samir ; Lasheen, Deena S |
| 2022 | A fluorescence-based assay to probe inhibitory effect of Fructose mimics on GLUT5 transport in breast Cancer cells | Rana, Natasha; Aziz, Marwa A; Wuest, Frank; Abouzid, Khaled AM; West, FG; Nermin Samir ; Serya, Rabah AT; Lasheen, Deena S |
| 15-Dec-2017 | How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors | Milik, Sandra N; Lasheen, Deena S; Serya, Rabah ; Abouzid, Khaled A M; Khaled A M Abouzid |
| 2019 | Selective Small Molecule Myeloid Cell Leukemia-1 (MCL-1) Inhibitors: Novel Agents in Cancer Therapy | Ibrahim, Hoda Sobhy; Lasheen, Deena S; Serya, Rabah ; Abu-ELElla, Dalal Abd-ELRahman |
| 2024 | Targeting apoptosis; design, synthesis and biological evaluation of new benzoxazole and thiazole based derivatives | Helmy, Sama W; Ella, Dalal A Abou El; Nermin Samir ; Shahin, Mai I; Lasheen, Deena S |
| 2026 | Towards the discovery of potent epigenetic modulators: Design, synthesis, biological evaluation, and SAR investigation of novel indole-based derivatives targeting HDAC1 and HDAC6 | Shawky, Sarah; Ahmed, Tarek Erfan; Haffez, Hesham; Sobhy, Aya; Soror, Sameh; Jaballah, Maiy; Henary, Maged; Nermin Samir ; Lasheen, Deena S |
